Position in INCY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$10,504,639
-$108,691 QoQ
Shares Held
111,609
+3.9% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CANADA LIFE ASSURANCE Co holds $291,138,584 across 78 Biotechnology names. INCY ranks #4 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
192,144 | $85,799,981 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
78,886 | $60,950,479 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
57,255 | $18,943,961 | |
| 4 | INCY |
Incyte Corp
This page
|
111,609 | $10,504,639 | |
| 5 | INSM |
INSMED Inc
|
53,890 | $8,812,092 | |
| 6 | ARGX |
Argenx SE
|
11,567 | $8,446,801 | |
| 7 | MRNA |
Moderna, Inc.
|
148,181 | $7,527,594 | |
| 8 | EXEL |
Exelixis, Inc.
|
167,451 | $7,181,973 |
All Filings in INCY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,504,639 | 111,609 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $10,613,330 | 107,455 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,887,478 | 140,166 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $8,813,774 | 129,424 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $7,593,938 | 125,416 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,032,836 | 130,778 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $11,720,455 | 177,314 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $11,072,667 | 182,657 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $10,173,873 | 178,583 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $13,166,937 | 209,698 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $13,000,387 | 225,037 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $14,119,856 | 226,825 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $14,024,788 | 194,061 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $14,265,554 | 177,609 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $11,145,739 | 167,253 | Shares | Sole | 2022-11-01 | |
| 2022-03-31 | $13,368,609 | 168,328 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $14,599,700 | 198,906 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $11,807,118 | 171,665 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $13,847,040 | 164,591 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $13,747,633 | 169,160 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $14,090,237 | 161,994 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $14,818,316 | 165,125 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $17,359,350 | 166,965 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $10,767,445 | 147,036 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||